Superoxide dismutase activity in tear fluid and blood of patients and mouse model of amyotrophic lateral sclerosis: a pilot study
PeerJ · 2025
DOI: 10.7717/peerj.19623 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Tatiana A Pavlenko und 12 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz National Medical Research Center for Eye Diseases of the Ministry of Health of the Russian Federation, Moscow, Russia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Tears, Superoxide Dismutase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Russian Science Foundation, PRNRMU.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by progressive degeneration of motor neurons and skeletal muscle atrophy. The heterogeneity of clinical symptoms and the lack of reliable biomarkers hamper diagnostics of ALS. The dysfunction of superoxide dismutase 1 (SOD1) protein is considered one of the molecular mechanisms underlying ALS pathology. We measured total SOD activity in the tear fluid and blood serum of ALS patients, healthy volunteers, and in the ALS mouse model, harboring the human truncated form of fused in sarcoma (FUS) protein—FUS (1–359). The average SOD activity in tear fluid did not differ between ALS patients and the control group. However, an increased proportion of patients with low SOD activity in tear fluid was observed compared to the control group. In contrast, SOD activity in blood serum was higher in the ALS group. Transgenic FUS (1–359) mice showed decreased SOD activity in tear fluid at both presymptomatic and symptomatic stages of ALS. SOD activity in blood serum did not differ between transgenic and control animals. These findings suggest that changes in SOD activity in the tear fluid of ALS patients and transgenic FUS (1–359) mice reflect local metabolic disturbances in the eyes associated with ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helmholtz National Medical Research Center for Eye Diseases of the Ministry of Health of the Russian Federation, Moscow, Russia.
- N. V. Sklifosovskiy Institute of Clinical Medicine, Moscow State Medical University (Sechenov University), Moscow, Russia.
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
- Department of General and Cell Biology, Faculty of Medical Biology, Pirogov Russian National Research Medical University, Moscow, Russia.
Förderung
- The Russian Science Foundation
- PRNRMU
Zitieren
APA
Pavlenko, T. A., Chesnokova, N. B., Beznos, O. V., Shikareva, N. N., Nodel, M. R., Shevtsova, K. V., Panina, U. V., Shteinberg, D. A., Kukharskaya, O. A., Sukhanova, I. S., Pukaeva, N. E., Kukharsky, M. S., & Ovchinnikov, R. K. (2025). Superoxide dismutase activity in tear fluid and blood of patients and mouse model of amyotrophic lateral sclerosis: a pilot study. PeerJ. https://doi.org/10.7717/peerj.19623
Vancouver
Pavlenko TA, Chesnokova NB, Beznos OV, Shikareva NN, Nodel MR, Shevtsova KV, et al. Superoxide dismutase activity in tear fluid and blood of patients and mouse model of amyotrophic lateral sclerosis: a pilot study. PeerJ. 2025. doi:10.7717/peerj.19623
BibTeX
@article{Pavlenko2025,
author = {Pavlenko, Tatiana A and Chesnokova, Natalia B and Beznos, Olga V and Shikareva, Natalia N and Nodel, Marina R and Shevtsova, Ksenia V and Panina, Uliana V and Shteinberg, Daniil A and Kukharskaya, Olga A and Sukhanova, Iuliia S and Pukaeva, Nadezhda E and Kukharsky, Michail S and Ovchinnikov, Ruslan K},
title = {Superoxide dismutase activity in tear fluid and blood of patients and mouse model of amyotrophic lateral sclerosis: a pilot study},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19623}
}
EUVIMED